Literature DB >> 7808841

Preliminary localization of a gene for autosomal dominant hypoparathyroidism to chromosome 3q13.

D N Finegold1, M M Armitage, M Galiani, T C Matise, M R Pandian, Y M Perry, R Deka, R E Ferrell.   

Abstract

A large family in which hypoparathyroidism was observed to segregate as an autosomal dominant trait in three generations was identified. Mutation in the PTH gene was excluded by linkage and single-stranded conformational analysis. The hypocalcemic phenotype in this family was mapped by linkage analysis using short, tandem-repeat polymorphisms to the region of chromosome 3q13. A maximum lod score of 2.71 at theta = 0.0 was observed with marker D3S1303. Positive lod scores were observed at theta = 0.0 with markers flanking D3S1303. Multipoint linkage analysis gave a lod score of 2.71 for the region flanking D3S1303. Simulation using the computer program SLINK showed that a lod score of 2.71 at theta = 0.0 was the maximum lod score possible given the pedigree structure. The simulation also showed that given the structure of the pedigree the probability of observing a lod score of 2.71 at theta = 0.0 by chance was 1 in 1000. The data presented above provide important preliminary evidence supporting linkage to chromosome 3q13. This region contains a Ca(2+)-sensing receptor gene that is proposed as a key signal transduction element for changes in extracellular Ca2+ concentrations in mechanisms of regulation of PTH secretion from parathyroid cells. The mutation in this family may activate the Ca(2+)-sensing receptor suppressing PTH secretion and lowering the "set point" for serum calcium levels.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7808841     DOI: 10.1203/00006450-199409000-00024

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  7 in total

Review 1.  Hypercalcaemic and hypocalcaemic conditions due to calcium-sensing receptor mutations.

Authors:  Ogo I Egbuna; Edward M Brown
Journal:  Best Pract Res Clin Rheumatol       Date:  2008-03       Impact factor: 4.098

2.  A novel mutation in Ca2+-sensing receptor gene in familial hypocalciuric hypercalcemia.

Authors:  T Nakayama; M Minato; M Nakagawa; M Soma; H Tobe; N Aoi; K Kosuge; M Sato; Y Ozawa; K Kanmatsuse; S Kokubun
Journal:  Endocrine       Date:  2001-08       Impact factor: 3.633

Review 3.  Genetic causes of hypercalciuric nephrolithiasis.

Authors:  Michael J Stechman; Nellie Y Loh; Rajesh V Thakker
Journal:  Pediatr Nephrol       Date:  2008-04-30       Impact factor: 3.714

4.  Insertion of an Alu sequence in the Ca(2+)-sensing receptor gene in familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism.

Authors:  N Janicic; Z Pausova; D E Cole; G N Hendy
Journal:  Am J Hum Genet       Date:  1995-04       Impact factor: 11.025

5.  Mapping of the calcium-sensing receptor gene (CASR) to human chromosome 3q13.3-21 by fluorescence in situ hybridization, and localization to rat chromosome 11 and mouse chromosome 16.

Authors:  N Janicic; E Soliman; Z Pausova; M F Seldin; M Rivière; J Szpirer; C Szpirer; G N Hendy
Journal:  Mamm Genome       Date:  1995-11       Impact factor: 2.957

6.  Homozygosity and linkage-disequilibrium mapping of the syndrome of congenital hypoparathyroidism, growth and mental retardation, and dysmorphism to a 1-cM interval on chromosome 1q42-43.

Authors:  R Parvari; E Hershkovitz; A Kanis; R Gorodischer; S Shalitin; V C Sheffield; R Carmi
Journal:  Am J Hum Genet       Date:  1998-07       Impact factor: 11.025

7.  Neonatal idiopathic primary hypoparathyroidism: A rare cause of neonatal seizures.

Authors:  Shabbir Hussain; Moin-Ud-Din Sabir; Mubaral Ali; Syed Awais-Ul-Hassan Shah
Journal:  Pak J Med Sci       Date:  2015 Sep-Oct       Impact factor: 1.088

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.